Professor Pallikaris joined the ESCRS Congress in Amsterdam presenting our product fixOflex and reporting our clinical experience with 108 patients from our clinical study in Alexandria of Egypt. You can visit ESCRS on Demand to watch recorded session from the Congress by clicking here.
EYE-PCR is participating with a presentation of fixOflex using the early outcome of a cohort of 108 patients from the on going Clinical Trial in Alexandria, Egypt. The presentation can be accessed by clicking here.
DetailsWe are proud to announce that we have successfully integrated 120 cases in the clinical study of Alexandria site. The initial trial launched in December 2019 at the Alexandria University, Egypt with Principal Investigators: Prof. Ahmed Elmassry and Prof. Osama Ibrahim and with the objective to perform the fixOflexTM implantation and 12-month follow up in 120 patients.
DetailsOn the 14th of May 2021 we have successfully initiated the additional trial that was planned at the University of Crete in Greece in which Principal Investigator is Prof. Efstathios Detorakis. The intention being for launching this extra clinical trial is to elaborate more on the clinical findings in a small number of patients.
EYE-PCR has presented a poster referring to the on going Clinical Trial in Alexandria. The early outcome of a cohort of 72 patients was promising. A video of Prof. Ioannis Pallikaris presenting the fixOflex Ring was released.
We report a case of a patient that was implanted with an intracapsular ring during phacoemulsification cataract surgery. Namely, we report on refraction, posterior capsule transparency and IOL ACD and document photographically the appearance of the posterior capsule. It is suggested that the presence of the intracapsular ring has inhibited epithelial cell migration and prevented…
DetailsEYE PCR is happy to announce that the abstract submitted by Prof Ahmed El Massry has been accepted
Cataract, is an opacification of the eye’s crystalline lens which leads to deterioration in visual performance and,
Today, Prof Ioannis Pallikaris announced the successful completion of the funding cycle permitted the
